89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,945,008 | -21.5% | 125,972 | -3.7% | 0.01% | -14.3% |
| Q2 2023 | $2,478,281 | +104.8% | 130,780 | +64.6% | 0.01% | +75.0% |
| Q1 2023 | $1,209,993 | +19.6% | 79,448 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $1,011,373 | +119.9% | 79,448 | 0.0% | 0.00% | +200.0% |
| Q3 2022 | $460,000 | +3.4% | 79,448 | -42.5% | 0.00% | 0.0% |
| Q2 2022 | $445,000 | -1.8% | 138,248 | +14.9% | 0.00% | 0.0% |
| Q1 2022 | $453,000 | -28.7% | 120,271 | +147.6% | 0.00% | 0.0% |
| Q4 2021 | $635,000 | -33.3% | 48,571 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $952,000 | +4.8% | 48,571 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $908,000 | -33.6% | 48,571 | -15.9% | 0.00% | -33.3% |
| Q1 2021 | $1,368,000 | -2.8% | 57,771 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,408,000 | – | 57,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
| Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
| Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
| Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
| Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
| Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
| Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
| Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |